1326
Vol. 58, No. 10
tive) m/z: 535.1488 [MϩNa]ϩ (Calcd for C29H24N2O7Na 535.1481). 152 °C
turn red, then decomposed.
N-(2-Hydroxybenzylidenyl)-4
-(3؆,4؆-methylenedioxyphenyl)-6
,
7
-dimethoxyl-1
-hydroxyl-benzyl-2,3-dihydro-isoindol-1-hydrazone (3)
1
White solid, yield 83%. H-NMR (DMSO-d6) d: 8.28 (1H, s), 7.59 (1H, s),
7.56 (1H, dd, Jϭ8.1, 1.5 Hz), 7.26 (1H, t, Jϭ7.8 Hz), 6.98 (1H, d, Jϭ7.8 Hz),
6.94—6.90 (3H, m), 6.84 (1H, d, Jϭ1.5 Hz), 6.73 (1H, dd, Jϭ8.1, 1.5 Hz),
6.08 (2H, s), 4.78 (2H, s), 3.89 (3H, s), 3.60 (3H, s). 13C-NMR (DMSO-d6)
d: 163.6, 157.4, 150.4, 149.8, 147.1, 146.8, 145.8, 144.1, 131.6, 130.1,
130.0, 129.6, 129.5, 129.1, 124.2, 124.1, 123.1, 119.9, 119.3, 116.8, 115.4,
111.7, 108.1, 105.9, 101.4, 55.9, 55.5, 44.6. MS (ESI) m/z: 499 (Mϩ). HR-
ESI-MS (positive) m/z: 521.1324 [MϩNa]ϩ (Calcd for C28H22N2O7Na
521.1325). 251 °C turn red, then decomposed.
Fig. 4. Western Blot Analysis of Protein Levels of Bcl-2, Bax in A549
Cells Treated with Compound 4
Compound 4 treated cell extracts were obtained and equal amounts of protein were
resolved by SDS-PAGE. Separated protein bands were transferred onto PVDF mem-
branes and incubated with specific primary and secondary antibodies, respectively.
Western blots were developed with enhanced chemiluminescence reagent. b-Actin was
used normalize total proteins.
N-(4-Methylbenzylidenyl)-4
-(3؆,4؆-methylenedioxyphenyl)-6
,7
-
dimethoxyl-1
-hydroxyl-benzyl-2,3-dihydro-isoindol-1-hydrazone
(4)
1
White solid, yield 87%. H-NMR (DMSO-d6) d: 8.10 (1H, s), 7.63 (1H, s),
7.60 (2H, s), 7.24 (1H, s), 7.21 (1H, s), 6.98 (1H, d, Jϭ8.1 Hz), 6.90 (1H, s),
6.82 (1H, d, Jϭ1.5 Hz), 6.72 (1H, dd, Jϭ7.8, 1.5 Hz), 6.08 (2H, s), 4.77 (2H,
s), 3.90 (3H, s), 3.60 (3H, s), 2.29 (3H, s). 13C-NMR (DMSO-d6) d: 163.9,
150.4, 149.8, 147.1, 146.7, 145.7, 143.7, 140.1, 132.5, 130.1, 129.8, 129.7,
128.9, 127.5, 124.8, 124.2, 123.1, 115.6, 111.7, 108.1, 106.1, 101.4, 101.3,
56.0, 55.5, 45.4, 21.5. MS (ESI) m/z: 497 (Mϩ). HR-ESI-MS (positive) m/z:
519.1522 (Calcd for C29H24N2O6Na 519.1532). 139 °C turn red, then decom-
posed.
c from the mitochondria during apoptosis mediated by the
mitochondrial pathway. In contrast, Bax can induce the re-
lease of cytochrome c from the mitochondria.17) The present
results revealed that compound 4 induced apoptosis via the
mitochondrial pathway accompanied by an increased expres-
sion of Bax and a decreased expression of Bcl-2 (Fig. 4).
N-(3,4,5-Trimethoxybenzylidenyl)-4
-(3؆,4؆-methylenedioxyphenyl)-
6
,7
-dimethoxyl-1
-hydroxyl-benzyl-2,3-dihydro-isoindol-1-hydrazone
(5) White solid, yield 80%.1H-NMR (DMSO-d6) d: 8.11 (1H, s), 7.64 (1H,
s), 7.07 (2H, s), 6.99 (1H, d, Jϭ8.1 Hz), 6.93 (1H, s), 6.84 (1H, d, Jϭ1.5
Hz), 6.73 (1H, dd, Jϭ8.1, 1.5 Hz), 6.08 (2H, d, Jϭ3.9 Hz), 4.80 (2H, s), 3.91
(3H, s), 3.81 (6 H, s), 3.68 (3H, s), 3.62 (3H, s). 13C-NMR (DMSO-d6) d:
163.9, 153.6, 150.4, 149.9, 147.1, 146.8, 145.8, 143.6, 139.5, 130.7, 130.1,
129.7, 128.9, 124.7, 124.2, 123.1, 115.8, 111.7, 108.1, 106.0, 104.8, 101.5,
101.3, 60.6, 56.4, 56.3, 56.0, 55.5, 45.6. MS (ESI) m/z: 573 (Mϩ). HR-ESI-
MS (positive) m/z: 595.1708 (Calcd for C31H28N2O9Na 595.1693). 155 °C
Conclusion
In the present study, we have described the preparation and
identification of benzoisoindolin hydrazones from diphyllin
in two steps. These derivatives displayed potent cytotoxic ac-
tivity against three human cancer cell lines. Compound 4
showed the highest cytotoxic potency. Apoptosis of HCT-116
cells induced by compound 4 was observed by Hoechst33342-
PI staining assay, AO-EB staining assay and Western blot
analysis. Compound 4 induced apoptosis via the mitochondr- turn red, then decomposed.
N-(3,4-Dimethoxybenzylidenyl)-4
-(3؆,4؆-methylenedioxyphenyl)-6
,7
-
dimethoxyl-1
-hydroxyl-benzyl-2,3-dihydro-isoindol-1-hydrazone (6)
ial pathway accompanied by an increased expression of Bax
and a decreased expression of Bcl-2. Our preclinical data in-
dicate that compound 4 is a potential therapeutic agent for
cancer.
White solid, yield 79%.1H-NMR (DMSO-d6) d: 8.06 (1H, s), 7.60 (1H, s),
7.34 (1H, d, Jϭ1.8 Hz), 7.19 (1H, dd, Jϭ8.4, 1.5 Hz), 6.98 (1H, d, Jϭ1.8
Hz), 6.95 (1H, s), 6.90 (1H, s), 6.81 (1H, d, Jϭ1.8 Hz), 6.71 (1H, dd, Jϭ7.8,
1.5 Hz), 6.07 (2H, d, Jϭ3.3 Hz), 4.76 (2H, s), 3.89 (3H, s), 3.75 (6H, s), 3.59
(3H, s). 13C-NMR (DMSO-d6) d: 163.8, 150.9, 150.3, 149.8, 149.4, 147.1,
146.7, 145.9, 143.6, 130.1, 129.6, 128.7, 127.9, 124.9, 124.2, 123.0, 122.1,
115.7, 111.9, 111.8, 108.7, 108.1, 105.9, 101.4, 101.3, 56.1, 56.0, 55.7,
55.5, 45.5. MS (ESI) m/z: 543 (Mϩ). HR-ESI-MS (positive) m/z: 565.1573
(Calcd for C30H26N2O8Na 565.1587). 151 °C turn red, then decomposed.
N-(4-Nitrobenzylidenyl)-4
-(3؆,4؆-methylenedioxyphenyl)-6
,7
-
Experimental
Syntheses Solvents were purified in the usual way. TLC was performed
on precoated Merck silica Gel 60 F254 plates. Flash chromatography was per-
1
formed on silica gel (100—200 mesh, Qingdao, China). H- and 13C-NMR
spectra were taken on a Bruker 300 MHz spectrometer with tetramethylsi-
lane (TMS) as an internal standard, and chemical shifts were recorded in val-
ues. The high resolution spectra were obtained on a Q-TOF Global Mass
(ESI-MS).
dimethoxyl-1
-hydroxyl-benzyl-2,3-dihydro-isoindol-1-hydrazone
(7)
Yellow solid, yield 87%. 1H-NMR (DMSO-d6) d: 8.27 (1H, s), 8.24 (1H, s),
8.20 (1H, s), 7.95 (1H, s), 7.92 (1H, s), 7.63 (1H, s), 7.01 (1H, d, Jϭ7.8 Hz),
6.92 (1H, s), 6.85 (1H, s), 6.75 (1H, d, Jϭ8.1 Hz), 6.11 (2H, s), 4.83 (2H, s),
3.91 (3H, s), 3.63 (3H, s). 13C-NMR (DMSO-d6) d: 164.1, 150.6, 149.9,
148.0, 147.2, 146.8, 146.0, 141.6, 140.9, 130.0, 129.7, 129.3, 128.2, 124.5,
124.3, 124.2, 123.4, 115.9, 111.7, 108.1, 106.1, 101.5, 101.4, 56.0, 55.6,
45.6. MS (ESI) m/z: 528 (Mϩ). HR-ESI-MS (positive) m/z: 550.1235 (Calcd
for C28H21N3O8Na 550.1226). 165 °C turn red, then decomposed.
4
-(3؆,4؆-Methylenedioxyphenyl)-6
,7
-dimethoxyl-1
-hydroxyl-benzyl-
2,3-dihydro-isoindol-1-one-hydrazine (1) To a stirred solution of diphyllin
(190 mg, 0.5 mmol) and in EtOH (30 ml) was added hydrazine hydrate (2 ml,
80%, 32 mmol). The mixture was maintained under reflux for 6 h, until TLC
indicated the end of reaction. The reaction mixture was cooled and the solid
was collected by filtration and washed with cool ethanol to afford a pale yel-
low solid 1 (170 mg, 87%). 1H-NMR (DMSO-d6) d: 7.59 (1H, s), 6.96 (1H,
d, Jϭ7.8 Hz), 6.91 (1H, s), 6.78 (1H, d, Jϭ1.5 Hz), 6.69 (1H, dd, Jϭ7.8, 1.5
Hz), 6.08 (2H, s), 4.81 (2H, s), 4.46 (2H, s), 3.91 (3H, s), 3.62 (3H, s). MS
(ESI) m/z: 395 (Mϩ). High resolution (HR)-ESI-MS (positive) m/z:
417.1066 [MϩNa]ϩ (Calcd for C21H18N2O6Na: 417.1063).
The hydrazones 2—11 were prepared as the following method: a solution
of 6 mmol of substituted aldehydes in ethanol was added to a solution of 5
mmol of 1 in 50 ml of ethanol. The mixture was refluxed on a water bath for
2—2.5 h. After cooling, the precipitate was filtered, dried and recrystallized
from ethanol.
N-(4-Fluorobenzylidenyl)-4
-(3؆,4؆-methylenedioxyphenyl)-6
,7
-
dimethoxyl-1
-hydroxyl-benzyl-2,3-dihydro-isoindol-1-hydrazone
(8)
White solid, yield 83%. 1H-NMR (DMSO-d6) d: 8.14 (1H, s), 7.78—7.73
(2H, m), 7.61 (1H, s), 7.29—7.23 (2H, m), 6.97 (1H, d, Jϭ7.8 Hz), 6.90
(1H, s), 6.82 (1H, d, Jϭ1.8 Hz), 6.71 (1H, dd, Jϭ7.8, 1.5 Hz), 6.11 (2H, s),
4.78 (2H, s), 3.89 (3H, s), 3.60 (3H, s). 13C-NMR (DMSO-d6) d: 165.0,
163.9, 150.3, 149.8, 147.1, 146.8, 145.9, 131.9, 130.1, 129.7, 129.5, 129.4,
128.9, 124.7, 124.2, 123.1, 116.5, 116.2, 115.7, 111.7, 108.1, 106.0, 101.4,
101.3, 56.0, 55.5, 45.5. MS (ESI) m/z: 501 (Mϩ). HR-ESI-MS (positive)
m/z: 523.1281 (Calcd for C28H21N2O6FNa 523.1281). 157 °C turn red, then
decomposed.
N-(3-Methoxybenzylidenyl)-4
-(3؆,4؆-methylenedioxyphenyl)-6
,7
-
dimethoxyl-1
-hydroxyl-benzyl-2,3-dihydro-isoindol-1-hydrazone
(2)
1
White solid, yield 82%. H-NMR (DMSO-d6) d: 8.15 (1H, s), 7.66 (1H, s),
7.34—7.33 (3H, m), 7.02 (1H, s), 6.99 (1H, s), 6.95 (1H, s), 6.85 (1H, d, Jϭ
1.5 Hz), 6.75 (1H, dd, Jϭ7.8, 1.5 Hz), 6.10 (2H, d, Jϭ1.5 Hz), 4.85 (2H, s),
3.93 (3H, s), 3.79 (3H, s), 3.64 (3H, s). 13C-NMR (DMSO-d6) d: 163.9,
160.0, 150.4, 149.8, 147.1, 146.8, 145.9, 143.2, 136.7, 130.4, 130.1, 129.7,
128.9, 124.7, 124.2, 123.1, 120.4, 116.3, 115.8, 111.7, 111.6, 108.1, 106.0,
101.4, 56.5, 56.0, 55.5, 45.8. MS (ESI) m/z: 513 (Mϩ). HR-ESI-MS (posi-
N-(4-Chlorobenzylidenyl)-4
-(3؆,4؆-methylenedioxyphenyl)-6
,
7
-dimethoxyl-1
-hydroxyl-benzyl-2,3-dihydro-isoindol-1-hydrazone (9)
1
White solid, yield 84%. H-NMR (DMSO-d6) d: 8.12 (1H, s), 7.73 (1H, s),
7.71 (1H, s), 7.62 (1H, s), 7.50 (1H, s), 7.47 (1H, s), 6.97 (1H, d, Jϭ7.8 Hz),
6.90 (1H, s), 6.82 (1H, s), 6.72 (1H, d, Jϭ7.8Hz), 6.08 (2H, s), 4.80 (2H, s),
3.89 (3H, s), 3.60 (3H, s). 13C-NMR (DMSO-d6) d: 163.9, 150.3, 149.8,
147.1, 146.8, 145.9, 142.0, 134.6, 134.2, 130.1, 129.7, 129.3, 128.9, 124.5,